TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T09960	C-C chemokine receptor type 5	B18MEX	4-[4-[[(3R)-3-[(R)-Cyclohexyl(hydroxy)methyl]-2,5-dioxo-1-(2,2,3,3,3-pentafluoropropyl)-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]-N-methylbenzamide;hydrochloride	Investigative	56668363	C33H40ClF5N4O5	703.1	CNC(=O)C1=CC=C(C=C1)OC2=CC=C(C=C2)CN3CCC4(CC3)C(=O)N[C@@H](C(=O)N4CC(C(F)(F)F)(F)F)[C@@H](C5CCCCC5)O.Cl	IC50 = 270000 nM	Non binder
T09960	C-C chemokine receptor type 5	B2GK3C	5-Methyl-1,10-phenanthroline	Investigative	72791	C13H10N2	194.23	CC1=CC2=C(C3=C1C=CC=N3)N=CC=C2	EC50 > 1000000 nM	Non binder
T09960	C-C chemokine receptor type 5	B3ULC5	4,4'-Dimethyl-2,2'-bipyridine	Investigative	14338	C12H12N2	184.24	CC1=CC(=NC=C1)C2=NC=CC(=C2)C	IC50 = 316227.77 nM	Non binder
T09960	C-C chemokine receptor type 5	B3XIP1	6,6'-Dimethyl-2,2'-bipyridine	Investigative	20445	C12H12N2	184.24	CC1=NC(=CC=C1)C2=CC=CC(=N2)C	IC50 = 501187.23 nM	Non binder
T09960	C-C chemokine receptor type 5	B5PB8T	1,10-Phenanthroline-4,7-diol	Investigative	77524	C12H8N2O2	212.2	C1=CC2=C(C3=C1C(=O)C=CN3)NC=CC2=O	IC50 > 1000000 nM	Non binder
T09960	C-C chemokine receptor type 5	B8YIN9	2,6-Bis(2-pyridyl)-4(1H)-pyridone	Investigative	619353	C15H11N3O	249.27	C1=CC=NC(=C1)C2=CC(=O)C=C(N2)C3=CC=CC=N3	IC50 = 501187.23 nM	Non binder
T09960	C-C chemokine receptor type 5	B93DVZ	4-[4-[[(3R)-1-(2-Aminoethyl)-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]-N-methylbenzamide;dihydrochloride	Investigative	69696607	C32H45Cl2N5O5	650.6	CNC(=O)C1=CC=C(C=C1)OC2=CC=C(C=C2)CN3CCC4(CC3)C(=O)N[C@@H](C(=O)N4CCN)[C@@H](C5CCCCC5)O.Cl.Cl	IC50 = 750000 nM	Non binder
T09960	C-C chemokine receptor type 5	BASF29	4-[4-[[(3S)-1-Butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride	Investigative	11947757	C33H44ClN3O6	614.2	CCCCN1C(=O)[C@@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CCCCC5)O.Cl	IC50 = 380000 nM	Non binder
T09960	C-C chemokine receptor type 5	BFZ05I	5-Chloro-1,10-phenanthroline	Investigative	77865	C12H7ClN2	214.65	C1=CC2=CC(=C3C=CC=NC3=C2N=C1)Cl	EC50 > 1000000 nM	Non binder
T09960	C-C chemokine receptor type 5	BGI8K7	4-[4-[[(3R)-3-[(R)-Cyclohexyl(hydroxy)methyl]-2,5-dioxo-1-(2,2,2-trifluoroethyl)-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]-N-methylbenzamide;hydrochloride	Investigative	56661529	C32H40ClF3N4O5	653.1	CNC(=O)C1=CC=C(C=C1)OC2=CC=C(C=C2)CN3CCC4(CC3)C(=O)N[C@@H](C(=O)N4CC(F)(F)F)[C@@H](C5CCCCC5)O.Cl	IC50 = 1148000 nM	Non binder
T09960	C-C chemokine receptor type 5	BH95OT	4,7-Dimethyl-1,10-phenanthroline	Investigative	72792	C14H12N2	208.26	CC1=C2C=CC3=C(C=CN=C3C2=NC=C1)C	IC50 = 300000 nM	Non binder
T09960	C-C chemokine receptor type 5	BI29RC	N-(1-Benzylpiperidin-4-yl)-2-(5-methyl-4-p-tolyl-4H-1,2,4-triazol-3-ylthio)acetamide	Investigative	16301115	C24H29N5OS	435.6	CC1=CC=C(C=C1)N2C(=NN=C2SCC(=O)NC3CCN(CC3)CC4=CC=CC=C4)C	IC50 = 269200 nM	Non binder
T09960	C-C chemokine receptor type 5	BKL2Z8	1,10-Phenanthroline-4,7-dicarbaldehyde	Investigative	14434082	C14H8N2O2	236.22	C1=CC2=C(C=CN=C2C3=NC=CC(=C31)C=O)C=O	IC50 > 1000000 nM	Non binder
T09960	C-C chemokine receptor type 5	BM67WT	4-[4-[[(3R)-3-[(R)-Cyclohexyl(hydroxy)methyl]-1-ethyl-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride	Investigative	56664936	C31H40ClN3O6	586.1	CCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CCCCC5)O.Cl	IC50 = 295000 nM	Non binder
T09960	C-C chemokine receptor type 5	BP1OW8	4-[4-[[(3R)-1-Butyl-3-[(1R)-1-hydroxy-2-methylpropyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride	Investigative	23577419	C30H40ClN3O6	574.1	CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C(C)C)O.Cl	IC50 = 229000 nM	Non binder
T09960	C-C chemokine receptor type 5	BP20FQ	4-[4-[[(3R)-3-[(R)-Cyclohexyl(hydroxy)methyl]-1-[2-(dimethylamino)ethyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]-N-methylbenzamide;dihydrochloride	Investigative	69697526	C34H49Cl2N5O5	678.7	CNC(=O)C1=CC=C(C=C1)OC2=CC=C(C=C2)CN3CCC4(CC3)C(=O)N[C@@H](C(=O)N4CCN(C)C)[C@@H](C5CCCCC5)O.Cl.Cl	IC50 = 640000 nM	Non binder
T09960	C-C chemokine receptor type 5	BR2OC9	N-[4-[5-(3,4-Dihydroxyphenyl)-3-oxo-pentyl]phenyl]-4-methoxy-benzamide	Investigative	129908559	C25H25NO5	419.5	COC1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)CCC(=O)CCC3=CC(=C(C=C3)O)O	EC50 > 200000 nM	Non binder
T09960	C-C chemokine receptor type 5	BU7Z9G	4,4'-Dimethoxy-2,2'-bipyridine	Investigative	2733927	C12H12N2O2	216.24	COC1=CC(=NC=C1)C2=NC=CC(=C2)OC	IC50 = 1511000 nM	Non binder
T09960	C-C chemokine receptor type 5	BZ4H5Q	4'-Chloro-2,2':6',2''-terpyridine	Investigative	667748	C15H10ClN3	267.71	C1=CC=NC(=C1)C2=CC(=CC(=N2)C3=CC=CC=N3)Cl	EC50 > 1000000 nM	Non binder
T09960	C-C chemokine receptor type 5	BZCH75	1,10-Phenanthroline-2,9-diyldimethanol	Investigative	336912	C14H12N2O2	240.26	C1=CC2=C(C3=C1C=CC(=N3)CO)N=C(C=C2)CO	IC50 = 587000 nM	Non binder